These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6382251)

  • 41. [Effect of ethambutol on severe pulmonary tuberculosis with special reference to bacteriological findings].
    Tamura M; Takazawa N; Asada T; Yamada M; Ikegaki H
    Kekkaku; 1969 Dec; 44(12):405-13. PubMed ID: 5372816
    [No Abstract]   [Full Text] [Related]  

  • 42. [Evaluation of short-term chemotherapy of pulmonary tuberculosis (2). (a trial of 6-month chemotherapy following negative conversion of the sputum)--a report on the 19th and 20th controlled trials series A of chemotherapy by the Cooperative Study Unit, Japan National Sanatoria)].
    Nagasawa S
    Kekkaku; 1983 Jun; 58(6):347-53. PubMed ID: 6353032
    [No Abstract]   [Full Text] [Related]  

  • 43. [Early results of Ethambutol treatment of 28 patients with pulmonary tuberculosis].
    Mysakowska H; Grodzki S; Przemyska B; Szarewicz-Adamczyk W; Marciniak T; Litwin B; Nowiński A
    Pol Tyg Lek; 1971 Feb; 26(8):271-3. PubMed ID: 5550443
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of patients with infiltrative tuberculosis of the lungs with tuberculin in combination with ethambutol and rifadin].
    Sattar IKh
    Probl Tuberk; 1984 May; (5):65-6. PubMed ID: 6377303
    [No Abstract]   [Full Text] [Related]  

  • 45. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Initial provisional record of treatment of relapses of active pulmonary tuberculosis with combined rifomycin, ethambutol and thiocarlide].
    Favez G; Willa C
    Acta Tuberc Pneumol Belg; 1969; 60(3):496-500. PubMed ID: 5392721
    [No Abstract]   [Full Text] [Related]  

  • 47. Tuberculous peritonitis developing during chemotherapy for pulmonary and intestinal tuberculosis: a case report.
    Kasahara K; Fukuoka A; Murakawa K; Okamura H; Mikasa K; Narita N; Kimura H
    Respirology; 2005 Mar; 10(2):257-60. PubMed ID: 15823196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effectiveness of chemotherapy of chronic forms of pulmonary tuberculosis under hospital conditions].
    Kolesnikov VV; Mikhaĭlov VI; Matviiakina TS
    Probl Tuberk; 1980 Mar; (3):41-4. PubMed ID: 7393892
    [No Abstract]   [Full Text] [Related]  

  • 50. A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.
    Pneumonologie; 1975 Dec; 153(1):43-59. PubMed ID: 1105471
    [No Abstract]   [Full Text] [Related]  

  • 51. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 52. [Etiopathogenic and therapeutical considerations on a case of primary multiple resistance to tuberculostatics].
    Golli V; Gherman M; Tufescu R
    Lille Med; 1973 Mar; 18(3):345-8. PubMed ID: 4727504
    [No Abstract]   [Full Text] [Related]  

  • 53. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract]   [Full Text] [Related]  

  • 55. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 56. [Ethambutol in chemotherapy of patients with fibro-cavitary tuberculosis of the lungs].
    Utkin VV; Poleshchuk AK; Zankisova IG; Mkrtchian SV; Krylova NP
    Probl Tuberk; 1971; 49(7):27-32. PubMed ID: 5004349
    [No Abstract]   [Full Text] [Related]  

  • 57. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethambutol in therapy of complicated tuberculosis.
    Tousek J; Papezová E
    Chemotherapy; 1973; 18(1):41-62. PubMed ID: 4681848
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effectiveness of rifampicin and ethambutol in chronic pulmonary tuberculosis].
    Anastasatu K; Sibila S; Kaufman S; Bercha O; Vais F
    Probl Tuberk; 1972; 50(5):28-30. PubMed ID: 5029675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.